Smith & Nephew bolsters sales force for SUPARTZ
This article was originally published in Clinica
Executive Summary
UK company Smith & Nephew (S&N) is stepping up the US launch of its SUPARTZ joint fluid therapy for the treatment of osteoarthritis of the knee by setting up a team of orthopaedic clinic-based specialists. The specialists will promote the new product, together with the company's 470-strong orthopaedic sales force.